Page 4 - Oral Solution News Today

Crude oil inventories in the U.S. unexpectedly pulled back sharply in the week ended April 19th, according to a report released by the Energy Information Administration on Wednesday.

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it is voluntarily recalling six (6) lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer leve

Dr. Reddys issues voluntary nationwide recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg due to Sub-potency FOR IMMEDIATE RELEASE Hyderabad...

Upsher-Smith has broadened its offerings to include Vigadrone (vigabatrin) Tablets, 500 mg. Torpenz Tablets, a branded-generic everolimus tablet, will soon be available to prescribers and patients.

/PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of Neurology (AAN)...

Camber introduced nearly one new generic product each week in Q1.

Here are the food & beverage, pet product, and drug/medical device recalls by the US Food and Drug Administration.

Some bottles may have been overfilled which can result in an over potent dosing regimen, Amneal said.

Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL, 150 mL, or 300 mL pack sizes, to the Consumer Level. Some bottles may have been overfilled which can res

FOR IMMEDIATE RELEASE- March 27, 2024 -Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey , is voluntarily recalling 4 lots of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL...